Doctor Alberto Cordero

Effectiveness of the Cardiovascular Polypill in patients with a previous cardiovascular event in hospitals and primary care centers in Spain: the NEPTUNO study. Subanalysis in patients with CHD

Event: ESC Preventive Cardiology 2022

Topic: Pharmacotherapy

Session: Rapid fire abstracts session 2 - Secondary Prevention and Rehabilitation

Access

0

Trends in major bleeding events in patients with acute coronary syndrome.

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Access

0

Gender differences low-density lipoprotein cholesterol reduction with PCSK9 inhibitors in real world patients

Event: ESC Congress 2021 - The Digital Experience

Topic: Drug therapy

Session: Risk Factors and Prevention ePosters

Access

0

The real-world cost and health resource utilization associated to the CNIC-polypill compared to usual care

Event: ESC Congress 2021 - The Digital Experience

Topic: Secondary Prevention

Session: Congress committee e-posters choice in preventive cardiology and special populations

Access

0

LDLc reduction with fixed-dose combination rosuvastatin-ezetimibe in patients with coronary heart disease that are not candidates for PCSK9 inhibitors treatment

Event: ESC Congress 2021 - The Digital Experience

Topic: Drug therapy

Session: Risk Factors and Prevention ePosters

Access

0

Clinical benefit of direct oral anticoagulants vs. vitamin-K antagonist in octogenarians with atrial fibrillation

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular Disease in Special Populations ePosters

Access

0

Trends in major bleeding events in patients with acute coronary syndrome.

Event: ACVC 2021

Topic: Epidemiology, Prognosis, Outcome

Session: Live Abstract session - Antithrombotics and bleeding

Access

0

Acute coronary syndrome patients with two minor high-bleeding risk criteria have the same bleeding rate that patients with one major criteria

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes - New Epidemiologic Data

Access

0

Validation of the Zwolle score for selection of very low-risk STEMI patients treated with primary angioplasty

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Acute Cardiac Care ePosters

Access

0

Effect of PCSK9 inhibitors treatment on acute coronary syndrome and stroke incidence: a metanalysis of currently available clinical trials

Event: ESC CONGRESS 2019

Topic: Drug therapy

Session: Lipid modification for the 21st century

Access

0

Doctor Alberto Cordero

Contributor content

Effectiveness of the Cardiovascular Polypill in patients with a previous cardiovascular event in hospitals and primary care centers in Spain: the NEPTUNO study. Subanalysis in patients with CHD

Trends in major bleeding events in patients with acute coronary syndrome.

Gender differences low-density lipoprotein cholesterol reduction with PCSK9 inhibitors in real world patients

The real-world cost and health resource utilization associated to the CNIC-polypill compared to usual care

LDLc reduction with fixed-dose combination rosuvastatin-ezetimibe in patients with coronary heart disease that are not candidates for PCSK9 inhibitors treatment

Clinical benefit of direct oral anticoagulants vs. vitamin-K antagonist in octogenarians with atrial fibrillation

Trends in major bleeding events in patients with acute coronary syndrome.

Acute coronary syndrome patients with two minor high-bleeding risk criteria have the same bleeding rate that patients with one major criteria

Validation of the Zwolle score for selection of very low-risk STEMI patients treated with primary angioplasty

Effect of PCSK9 inhibitors treatment on acute coronary syndrome and stroke incidence: a metanalysis of currently available clinical trials

This platform is supported by